NCAN and early-onset autosomal dominant Alzheimer disease: Plasma levels of both NCAN and BCAN have previously been shown to be positively associated with general cognitive function and DSST performance [9], whilst BCAN levels have been found to be positively associated with Mini Mental State Examination performance and reduced in patients with Alzheimer’s disease or mild cognitive impairment [7].